Підписатись
Abhishek Ghara
Abhishek Ghara
Acharya & BM Reddy College of Pharmacy
Підтверджена електронна адреса в acharya.ac.in
Назва
Посилання
Посилання
Рік
Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer
SVB Gurubasavaraj Swamy Purawarga Matada, Prasad Sanjay Dhiwar, Nahid Abbas ...
Journal of Biomolecular Structure and Dynamics, 2021
30*2021
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
PSDAG Gurubasavaraja Swamy Purawarga Matada, Arka Das
Medicinal Chemistry Research 30 (3), 535-551, 2021
262021
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a r eview
E Singh, GSP Matada, N Abbas, PS Dhiwar, A Ghara, A Das
Inflammopharmacology 29 (5), 1347-1355, 2021
232021
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
PS Dhiwar, GS Purawarga Matada, R Pal, E Singh, A Ghara, L Maji, ...
Journal of Biomolecular Structure and Dynamics 42 (3), 1564-1581, 2024
162024
Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach
GSP Matada, PS Dhiwar, N Abbas, E Singh, A Ghara, R Patil, ...
Journal of Molecular Structure 1257, 132531, 2022
112022
Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies
G Swamy PM, N Abbas, PS Dhiwar, E Singh, A Ghara, A Das
Journal of Biomolecular Structure and Dynamics 41 (1), 125-146, 2023
102023
An updated literature on BRAF inhibitors (2018–2023)
L Maji, G Teli, NM Raghavendra, S Sengupta, R Pal, A Ghara, ...
Molecular Diversity 28 (4), 2689-2730, 2024
72024
Molecular recognition of some novel mTOR kinase inhibitors to develop anticancer leads by drug-likeness, molecular docking and molecular dynamics based virtual screening strategy
A Das, GSP Matada, PS Dhiwar, NM Raghavendra, N Abbas, E Singh, ...
Computational Toxicology 25, 100257, 2023
72023
Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer
PS Dhiwar, GSP Matada, NM Raghavendra, A Ghara, E Singh, N Abbas, ...
Medicinal Chemistry Research 31 (9), 1401-1413, 2022
62022
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I Aayishamma, GSP Matada, R Pal, A Ghara, NVSS Aishwarya, ...
European Journal of Medicinal Chemistry, 116831, 2024
42024
Exploring the molecular insights of imidazole and benzimidazole scaffold for cancer therapy: Synthesis, in-vitro cytotoxicity and SAR studies
A Ghara, GSP Matada, P Pramanick, UR Sharma, B Metikurki, PS Dhiwar
Journal of Molecular Structure, 140324, 2024
32024
Expanding the potential of pyridine scaffold for targeted therapy of cancer: biological activity, molecular insights, and structure-activity relationship
NVSS Aishwarya, GSP Matada, R Pal, I Aayishamma, KR Hosamani, ...
Journal of Molecular Structure, 139655, 2024
32024
A detailed study of Transition Metal Complexes of a Schiff base with its Physico-chemical properties by using an electrochemical method
A Ghara
Asian Journal of Pharmacy and Pharmacology 3 (3), 86-94, 2017
3*2017
Exploring Thiazolidine-2, 4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
MP Viji, GSP Matada, R Pal, A Ghara, PK Das, BV Manjushree, ...
Journal of Molecular Structure, 140529, 2024
12024
Rheumatoid arthritis-associated complications during pregnancy and its effect on offspring: comprehensive review
S Rohini, UR Sharma, M Vinutha, D Shreelaxmi, S Vada, S Janandri, ...
Inflammopharmacology 32 (4), 1-17, 2024
12024
MULTITARGET HISTONE DEACETYLASE INHIBITORS WITH REDUCED BRD4-LIFR-JAK1-STAT3-MEDIATED DRUG RESISTANCE.
J Pandey, M Mandha, MR Khan, A Ghara, S Nayak, G Chakraborthy, ...
Biochemical & Cellular Archives 24 (2), 2024
2024
Design and Synthesis of Tri-substituted Imidazole Derivatives as CD73 Inhibitors for Their Anticancer Activity
A Ghara, GS Andhale, GSP Matada, PS Dhiwar
Letters in Drug Design & Discovery 19 (3), 242-255, 2022
2022
In-Silico Design, Synthesis, and In-Vitro Anti-Tuberculosis Activity of Novel Hybrid 1, 3, 4-Oxadiazol-Pyridopyridazine Scaffolds
A Ghara, GS PM, J KR, PK Das, FB Zanchi
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–18